Encellin Secures $9.9M in Funding to Advance Revolutionary EnCRT for Type 1 Diabetes
Key Highlights $9.9M financing round led by Khosla Ventures, with Y Combinator’s participation. Encellin’s EnCRT aims to transform T1D treatment with…
Browsing Tag
UCSF Desai Lab
1 post